153 related articles for article (PubMed ID: 38785960)
1. LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond.
Kim HM; Liu Z
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785960
[TBL] [Abstract][Full Text] [Related]
2. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.
Fang R; Barbera AJ; Xu Y; Rutenberg M; Leonor T; Bi Q; Lan F; Mei P; Yuan GC; Lian C; Peng J; Cheng D; Sui G; Kaiser UB; Shi Y; Shi YG
Mol Cell; 2010 Jul; 39(2):222-33. PubMed ID: 20670891
[TBL] [Abstract][Full Text] [Related]
3. The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.
Malagraba G; Yarmohammadi M; Javed A; Barceló C; Rubio-Tomás T
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327654
[TBL] [Abstract][Full Text] [Related]
4. Histone demethylase LSD2 acts as an E3 ubiquitin ligase and inhibits cancer cell growth through promoting proteasomal degradation of OGT.
Yang Y; Yin X; Yang H; Xu Y
Mol Cell; 2015 Apr; 58(1):47-59. PubMed ID: 25773598
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2).
Mino K; Nishimura S; Ninomiya S; Tujii H; Matsumori Y; Tsuchida M; Hosoi M; Koseki K; Wada S; Hasegawa M; Sasaki R; Murakami-Yamaguchi Y; Narita H; Suzuki T; Miyata N; Mizukami T
Biosci Biotechnol Biochem; 2014; 78(6):1010-7. PubMed ID: 25036127
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
[TBL] [Abstract][Full Text] [Related]
7. Structure-function analysis reveals a novel mechanism for regulation of histone demethylase LSD2/AOF1/KDM1b.
Zhang Q; Qi S; Xu M; Yu L; Tao Y; Deng Z; Wu W; Li J; Chen Z; Wong J
Cell Res; 2013 Feb; 23(2):225-41. PubMed ID: 23266887
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
Hino S; Kohrogi K; Nakao M
Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
[TBL] [Abstract][Full Text] [Related]
9. The Catalytic-Dependent and -Independent Roles of Lsd1 and Lsd2 Lysine Demethylases in Heterochromatin Formation in
Marayati BF; Tucker JF; Cerda DA; Hou TC; Chen R; Sugiyama T; Pease JB; Zhang K
Cells; 2020 Apr; 9(4):. PubMed ID: 32295063
[TBL] [Abstract][Full Text] [Related]
10. A novel mammalian flavin-dependent histone demethylase.
Karytinos A; Forneris F; Profumo A; Ciossani G; Battaglioli E; Binda C; Mattevi A
J Biol Chem; 2009 Jun; 284(26):17775-82. PubMed ID: 19407342
[TBL] [Abstract][Full Text] [Related]
11. A Tail-Based Mechanism Drives Nucleosome Demethylation by the LSD2/NPAC Multimeric Complex.
Marabelli C; Marrocco B; Pilotto S; Chittori S; Picaud S; Marchese S; Ciossani G; Forneris F; Filippakopoulos P; Schoehn G; Rhodes D; Subramaniam S; Mattevi A
Cell Rep; 2019 Apr; 27(2):387-399.e7. PubMed ID: 30970244
[TBL] [Abstract][Full Text] [Related]
12. Lysine-specific histone demethylase 1B (LSD2/KDM1B) represses p53 expression to promote proliferation and inhibit apoptosis in colorectal cancer through LSD2-mediated H3K4me2 demethylation.
Cai S; Wang J; Zeng W; Cheng X; Liu L; Li W
Aging (Albany NY); 2020 Jul; 12(14):14990-15001. PubMed ID: 32726297
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression.
Chen L; Vasilatos SN; Qin Y; Katz TA; Cao C; Wu H; Tasdemir N; Levine KM; Oesterreich S; Davidson NE; Huang Y
Oncotarget; 2017 Oct; 8(47):81737-81753. PubMed ID: 29137219
[TBL] [Abstract][Full Text] [Related]
14. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
Laurent B; Shi Y
Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
[TBL] [Abstract][Full Text] [Related]
15. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
16. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
[TBL] [Abstract][Full Text] [Related]
17. Histone demethylases in chromatin biology and beyond.
Dimitrova E; Turberfield AH; Klose RJ
EMBO Rep; 2015 Dec; 16(12):1620-39. PubMed ID: 26564907
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE
Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019
[TBL] [Abstract][Full Text] [Related]
19. The histone demethylase LSD1/KDM1A promotes the DNA damage response.
Mosammaparast N; Kim H; Laurent B; Zhao Y; Lim HJ; Majid MC; Dango S; Luo Y; Hempel K; Sowa ME; Gygi SP; Steen H; Harper JW; Yankner B; Shi Y
J Cell Biol; 2013 Nov; 203(3):457-70. PubMed ID: 24217620
[TBL] [Abstract][Full Text] [Related]
20. The NPAC-LSD2 complex in nucleosome demethylation.
Caroli J; Mattevi A
Enzymes; 2023; 53():97-111. PubMed ID: 37748839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
